T lymphocytes of HIV-positive individuals: Preloaded guns in spite of highly active antiretroviral therapy?

AIDS

Volumn 18, Issue 2, 2004, Pages 327-328

  Poli, Guido ^a,b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b P2 P3 Laboratories   (Italy)

Author keywords

Chemokines; Cyclic adenosine monophosphate; Cytokines; Gene expression; Highly active antiretroviral therapy

Indexed keywords

ANTIRETROVIRUS AGENT; CELL ADHESION MOLECULE; CHEMOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; INTEGRIN; INTERLEUKIN 2; MESSENGER RNA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

DATA ANALYSIS; DOWN REGULATION; EDITORIAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; RNA, MESSENGER; RNA, VIRAL; T-LYMPHOCYTES;

EID: 1342289517     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200401230-00025     Document Type: Editorial

References (9)

1. Alfano M, Poli G. The cytokine network in HIV infection. Curr Mol Med 2002, 2:677-689.
2. Kovacs JA, Baseler M, Dewar RJ, Vogel S, Davey RT Jr, Falloon J, et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study [see Comments]. N Engl J Med 1995, 332:567-575.
3. Johansson CC, Bryn T, Yndestad A, Eiken HG, Bjerkeli V, Froland SS, et al. Cytokine networks are pre-activated in T cells from HIV-infected patients on HAART and under control of cAMP. AIDS 2004, 18:171-179.
4. Orenstein JM, Bhat N, Yoder C, Fox C, Polis MA, Metcalf JA, et al. Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression. AIDS 2000, 14:1709-1715.
5. Davey RT Jr, Bhat N, Yoder C, Chun TW, Metcalf JA, Dewar R, et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression [in Process Citation]. Proc Natl Acad Sci U S A 1999, 96:15109-15114.
6. Schindler R, Clark BD, Dinarello CA. Dissociation between interleukin-1 beta mRNA and protein synthesis in human peripheral blood mononuclear cells. J Biol Chem 1990, 265:10232-10237.
7. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.
8. Zou W, Foussat A, Houhou S, Durand-Gasselin I, Dulioust A, Bouchet L, et al. Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2. ANRS 048 IL-2 Study Group. AIDS 1999, 13:455-463.
9. Tambussi G, Ghezzi S, Nozza S, Vallanti G, Magenta L, Guffanti M, et al. Efficacy of low-dose intermittent subcutaneous interleukin (IL)-2 in antiviral drug-experienced human immunodeficiency virus-infected persons with detectable virus load: a controlled study of 3 IL-2 regimens with antiviral drug therapy. J Infect Dis 2001, 183:1476-1484.